Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

De novopurine biosynthesis is a major driver of chemoresistance in glioblastoma
Jack Shireman, Fatemeh Atashi, Gina Lee, et al.
Brain (2021) Vol. 144, Iss. 4, pp. 1230-1246
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Nucleotide metabolism: a pan-cancer metabolic dependency
Nicholas J. Mullen, Pankaj K. Singh
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 275-294
Open Access | Times Cited: 182
Regulation of nucleotide metabolism in cancers and immune disorders
Eunüs S. Ali, Issam Ben‐Sahra
Trends in Cell Biology (2023) Vol. 33, Iss. 11, pp. 950-966
Open Access | Times Cited: 44
Emerging roles of nucleotide metabolism in cancer
Diana D. Shi, Milan R. Savani, Kalil G. Abdullah, et al.
Trends in cancer (2023) Vol. 9, Iss. 8, pp. 624-635
Open Access | Times Cited: 32
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Chloé Bernhard, Damien Reita, Sophie Martin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9137-9137
Open Access | Times Cited: 31
CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio
Wentao Hu, Xing Cui, Hongyu Liu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer
Tatiane da Silva Fernandes, Bryan M. Gillard, Tao Dai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production
Ella Perrault, Jack Shireman, Eunüs S. Ali, et al.
Science Advances (2023) Vol. 9, Iss. 20
Open Access | Times Cited: 18
Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data
Dimitra Smerdi, Myrto Moutafi, Ioannis Kotsantis, et al.
Life (2024) Vol. 14, Iss. 6, pp. 673-673
Open Access | Times Cited: 6
ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling
Limin Chen, Xinsheng Xie, Tiantian Wang, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 5, pp. 871-885
Open Access | Times Cited: 26
The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma
Qiong Wu, Anders Berglund, Robert J.B. Macaulay, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 942-942
Open Access | Times Cited: 5
Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling
Derrick Lee, Ryan C. Gimple, Xujia Wu, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 2
Open Access | Times Cited: 20
Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity
Ping Shi, Jia Tian, Brittany Ulm, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
Erik R. Peterson, Peter Sajjakulnukit, Andrew J. Scott, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Oxidative stress induced protein aggregation via GGCT produced pyroglutamic acid in drug resistant glioblastoma
Deanna Tiek, Xiao Song, Xiaozhou Yu, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111769-111769
Open Access
Transketolase attenuates the chemotherapy sensitivity of glioma cells by modulating R-loop formation
Minjie Fu, Mengli Zhang, Licheng Zhang, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115142-115142
Open Access
Investigating the relevance of nucleotide metabolism in the prognosis of glioblastoma through bioinformatics models
Lu-Wei Jiang, Zixuan Li, Xiao Ji, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The influence of IMPDH activity on ciliogenesis and adipogenesis of 3T3-L1 cells while undergoing differentiation
Kolsoom Shahdadnejad, Razieh Yazdanparast
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2025), pp. 159603-159603
Closed Access
Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance
Simona D’Aprile, Simona Denaro, Anna Gervasi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Elucidating prognostic significance of purine metabolism in colorectal cancer through integrating data from transcriptomic, immunohistochemical, and single‐cell RNA sequencing analysis
Sung-Yeon Kim, Myunghee Kang, Soyeon Jeong, et al.
Molecular Oncology (2025)
Open Access
IMPDH2's Central Role in Cellular Growth and Diseases: A Potential Therapeutic Target
Zheng Li, Yingbing Zou, Jianzhao Niu, et al.
Cell Proliferation (2025)
Open Access
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment
Simona D’Aprile, Simona Denaro, Filippo Torrisi, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
IMPDH Inhibition Decreases TERT Expression and Synergizes the Cytotoxic Effect of Chemotherapeutic Agents in Glioblastoma Cells
X. Liu, Junying Wang, Laura Wu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5992-5992
Open Access | Times Cited: 3
IMPDH inhibitors upregulate PD-L1 in cancer cells without impairing immune checkpoint inhibitor efficacy
Mingming Zheng, Jiayi Li, Hongjie Guo, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 3
Comprehensive Analysis of Purine-Metabolism-Related Gene Signature for Predicting Ovarian Cancer Prognosis, Immune Landscape, and Potential Treatment Options
Jingchun Liu, Xiaoyi Zhang, Haoyu Wang, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 776-776
Open Access | Times Cited: 7
Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma
Yu-Jung Chen, Swathi V. Iyer, David Chun-Cheng Hsieh, et al.
Nature (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top